MAPT and Alzheimer disease: However, further studies using new antibodies directed to AIS markers, in combination with antibodies that recognize tau that is phosphorylated at additional residues, will be helpful to gain deeper insight into AIS vulnerability to the progression of tau hyperphosphorylation during the course of AD.